SignatureFD’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$66.2K Buy
1,686
+1,124
+200% +$43.4K ﹤0.01% 1794
2026
Q2
$20.5K Buy
562
+351
+166% +$11.1K ﹤0.01% 2334
2026
Q1
$5.91K Sell
211
-34
-14% -$1.12K ﹤0.01% 2722
2025
Q4
$9.17K Hold
245
– – ﹤0.01% 2469
2025
Q3
$6.75K Buy
245
+5
+2% +$172 ﹤0.01% 2546
2025
Q2
$7.58K Sell
240
-60
-20% -$1.93K ﹤0.01% 2446
2025
Q1
$10K Hold
300
– – ﹤0.01% 2361
2024
Q4
$10.3K Hold
300
– – ﹤0.01% 2354
2024
Q3
$12K Hold
300
– – ﹤0.01% 2263
2024
Q2
$9.05K Sell
300
-132
-31% -$3.97K ﹤0.01% 2311
2024
Q1
$14.5K Sell
432
-67
-13% -$2.15K ﹤0.01% 2161
2023
Q4
$16.1K Buy
499
+469
+1,563% +$13.1K ﹤0.01% 2030
2023
Q3
$983 Sell
30
-207
-87% -$7.19K ﹤0.01% 2940
2023
Q2
$8.34K Buy
237
+213
+888% +$7.35K ﹤0.01% 2317
2023
Q1
$784 Sell
24
-71
-75% -$3.23K ﹤0.01% 3037
2022
Q4
$5.24K Hold
95
– – ﹤0.01% 2462
2022
Q3
$4K Buy
95
+25
+36% +$1.22K ﹤0.01% 2525
2022
Q2
$3K Buy
+70
New +$3.15K ﹤0.01% 2619
2022
Q1
– Sell
-5
Closed – – 3217
2021
Q4
$0 Buy
+5
New +$199 ﹤0.01% 3172

Other funds holding HRMY

SignatureFD's HRMY Position: Q3 2026 in Review

SignatureFD increased its Harmony Biosciences (HRMY) stake by 200% in Q3 2026, buying an estimated $43.4K and bringing the position to 1,686 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

SignatureFD first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. 99 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • SignatureFD held 1,686 shares of Harmony Biosciences worth $66.2K as of Q3 2026.
  • SignatureFD bought 1,124 Harmony Biosciences shares in Q3 2026, an estimated $43.4K.
  • Harmony Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1794 holding.
  • SignatureFD first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 99 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.